SRF and Alzheimer disease: The results of the ChIP-Atlas analysis indicated that SRF has the potential to bind to 17 AD-related genes, including apolipoprotein E (APOE), which is a major risk factor for AD32 (Fig. 4b, c, Supplementary Fig. 9a).